Back to Journals » Neurobehavioral HIV Medicine » Volume 2

Exploration of a genomic expression and pathway analysis approach to neurocognitive performance: preliminary findings

Authors Chad A Bousman, Gursharan Chana, Stephen J Glatt, et al

Published 12 July 2010 Volume 2010:2 Pages 23—32

DOI https://doi.org/10.2147/NBHIV.S12354

Review by Single-blind

Peer reviewer comments 2

Chad A Bousman1, Gursharan Chana2, Stephen J Glatt3, Sharon D Chandler1, Todd May1, James Lohr1, Ian P Everall2, William S Kremen1, Ming T Tsuang1

1Psychiatry, University of California, San Diego, CA, USA; 2Psychiatry, University of Melbourne, Melbourne, Victoria, Australia; 3Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA

Abstract: Identification of genomic biomarkers for neurocognitive performance could ­revolutionize screening, diagnosis, staging, and/or prognosis practices for HIV-associated neurocognitive disorders (HAND). This study sought to explore the relationship between blood-based gene expression and neurocognitive performance. 8 healthy adults were recruited. Subjects were non-smokers, reported taking no medications, and were free of any psychiatric disorders. Correlations adjusting for education and ancestry were conducted to generate lists of genes significantly correlated with scores on neurocognitive test from the National Institute of Mental Health’s Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) consensus cognitive battery (MCCB). Ingenuity pathway analysis was used to identify canonical pathways. For each of the 10 MCCB tests, large effect sizes (r > 0.49) were observed. 65% of the genes and 80% of canonical pathways were unique to 1 of the 10 MCCB tests, albeit none survived a 10% FDR correction. Minimal gene overlap was observed across tests; however, several overlapping canonical pathways were observed. Analysis of the relationship between gene expression alterations and neurocognitive performance may provide the potential for improving our ability to identify genomic markers of HAND as well as provide guidance to physicians and researchers in HIV medicine and other disciplines in their pursuit of viable genomic biomarkers for neurocognitive impairment.

Keywords: gene expression, cognitive, methodology, MATRICS

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Other article by this author:

Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine

Chad A Bousman, Mariana Cherner, Stephen J Glatt, et al

Neurobehavioral HIV Medicine 2010, 2:1-11

Published Date: 14 January 2010

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Acquired hemophilia A: emerging treatment options

Janbain M, Leissinger CA, Kruse-Jarres R

Journal of Blood Medicine 2015, 6:143-150

Published Date: 8 May 2015

A new recombinant factor VIII: from genetics to clinical use

Santagostino E

Drug Design, Development and Therapy 2014, 8:2507-2515

Published Date: 12 December 2014

Second case report of successful electroconvulsive therapy for a patient with schizophrenia and severe hemophilia A

Saito N, Shioda K, Nisijima K, Kobayashi T, Kato S

Neuropsychiatric Disease and Treatment 2014, 10:865-867

Published Date: 16 May 2014

Rituximab for managing acquired hemophilia A in a case of chronic neutrophilic leukemia with the JAK2 kinase V617F mutation

Imashuku S, Kudo N, Kubo K, Saigo K, Okuno N, Tohyama K

Journal of Blood Medicine 2012, 3:157-161

Published Date: 5 December 2012

Anti-Factor V inhibitor in patients with autoimmune diseases: case report and literature review

Imashuku S, Hasegawa T, Kubo K, Nakato M, Shima M

International Medical Case Reports Journal 2011, 4:31-34

Published Date: 20 April 2011